Last reviewed · How we verify
Phase 3 Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Recurrent or Metastatic Esophageal Carcinoma
The purpose of this study is to evaluate the efficacy and the toxicity of lobaplatin, 5-fluorouracil (5-FU) and leucovorin in patients with esophageal carcinoma.
Details
| Lead sponsor | Taian Cancer Hospital |
|---|---|
| Phase | Phase 3 |
| Status | UNKNOWN |
| Enrolment | 120 |
| Start date | 2009-12 |
| Completion | 2010-12 |
Conditions
- Esophageal Carcinoma
Interventions
- lobaplatin , 5-FU ,leucovorin
Primary outcomes
- objective response rate(ORR) time to progression (TTP) toxicities — 12/31/2010
Countries
China